(Q30990725)

28 June 2017

Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation (English)

1 reference

28 June 2017

7

Singletary SE

1 reference

28 June 2017

Katz A

1

1 reference

28 June 2017

Buchholz TA

2

1 reference

28 June 2017

Thames H

3

1 reference

28 June 2017

Smith CD

4

1 reference

28 June 2017

McNeese MD

5

1 reference

28 June 2017

Theriault R

6

1 reference

28 June 2017

Strom EA

8

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

International Journal of Radiation Oncology Biology Physics

28 June 2017

1 reference

28 June 2017

50

1 reference

28 June 2017

2

1 reference

28 June 2017

397-403

1 reference

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

FAC + BCG as adjuvant therapy in breast cancer: an 8-year update

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Ten-year results of FAC adjuvant chemotherapy trial in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901465-1

7 January 2021

10.1016/S0360-3016(01)01465-1

Identifiers

DOI

1 reference

28 June 2017

1 reference